Complete characterization of the microRNAome in a patient with acute myeloid leukemia
about
An in silico analysis of dynamic changes in microRNA expression profiles in stepwise development of nasopharyngeal carcinomaSequencing technologies and genome sequencingThe dark matter of the cancer genome: aberrations in regulatory elements, untranslated regions, splice sites, non-coding RNA and synonymous mutationsAnalysis of Genomic Sequence Motifs for Deciphering Transcription Factor Binding and Transcriptional Regulation in Eukaryotic CellsEpigenomics of leukemia: from mechanisms to therapeutic applicationsNext-generation sequencing: from understanding biology to personalized medicine.Discovery of new microRNAs by small RNAome deep sequencing in childhood acute lymphoblastic leukemia.miR-125a regulates cell cycle, proliferation, and apoptosis by targeting the ErbB pathway in acute myeloid leukemiaEvaluation of normalization methods in mammalian microRNA-Seq data.Integrative analysis of somatic mutations altering microRNA targeting in cancer genomes.Targeted resequencing of the microRNAome and 3'UTRome reveals functional germline DNA variants with altered prevalence in epithelial ovarian cancer.Reduced DICER1 elicits an interferon response in endometrial cancer cellsMicroRNA genes and their target 3'-untranslated regions are infrequently somatically mutated in ovarian cancersNovel insight into the non-coding repertoire through deep sequencing analysis.SomamiR: a database for somatic mutations impacting microRNA function in cancer.MicroRNA-142 is mutated in about 20% of diffuse large B-cell lymphomaGenetic variation and its role in malignancyAre results of targeted gene sequencing ready to be used for clinical decision making for patients with acute myelogenous leukemia?OncomiR or Tumor Suppressor? The Duplicity of MicroRNAs in Cancer.Acquired copy number alterations of miRNA genes in acute myeloid leukemia are uncommonGenomics of acute myeloid leukemia: the next generation.MicroRNAs in myeloid malignancies.Genomic tools in acute myeloid leukemia: From the bench to the bedsideAnti-microRNAs as Novel Therapeutic Agents in the Clinical Management of Alzheimer's Disease.PPI-G4 Glycodendrimers Upregulate TRAIL-Induced Apoptosis in Chronic Lymphocytic Leukemia Cells.Combined evaluation of a panel of protein and miRNA serum-exosome biomarkers for pancreatic cancer diagnosis increases sensitivity and specificity.miR-125b predicts childhood acute lymphoblastic leukaemia poor response to BFM chemotherapy treatment.E2F1 somatic mutation within miRNA target site impairs gene regulation in colorectal cancer.miRNA-mediated deregulation in leukemia.How novel molecular diagnostic technologies and biomarkers are revolutionizing genetic testing and patient care.Next generation sequencing: potential and application in drug discoveryMiR-10a and HOXB4 are overexpressed in atypical myeloproliferative neoplasms
P2860
Q21202158-3B0708C1-80F8-4FA6-B672-442C7ED37597Q24635185-C6021D99-2EA8-4D77-AC84-881DD9075CD8Q26753387-6B00B81D-608C-4931-AFA1-B066B1867B24Q26768509-C3B6E76B-7A84-42E3-8030-776B0965CCA4Q26823403-A7881925-CCE4-4D5B-A37A-D04B591459EDQ33565443-3103611F-0BED-42C6-96CB-74BECC33E6F5Q33909896-0AEE82BD-3E21-4B17-AB76-A5AB8DDC6363Q33982491-34930CB8-949F-4292-98A9-C6EB63C27DF2Q34244842-CCBB4F24-90CC-4D92-AA90-E8A10507FCE2Q34455163-590F650E-F631-4292-B26F-5CBA37930E2BQ35079572-EBDDBDF6-F6FD-40E4-A015-DCF820573F4EQ35840362-0A0E5050-886F-4B1D-B9A3-1392A758F64BQ35908632-7AB27866-0543-4C61-85C8-7FECB5CB9EE6Q36008219-D71ACEC3-CBFB-45B1-8DB9-6D1BAE6C58CFQ36491386-D70C7FC3-A852-438B-B052-42D749951C1AQ36530696-FAC54A2E-DD08-494E-BB72-A73E6BA094FFQ36735686-52782E1A-7AC0-447B-9353-2188AB7CBA35Q36949511-1BED1EC4-DD57-46B7-87A6-DC7EA97569B5Q37059796-FE29104B-3A41-4C39-973F-58A499DF0725Q37226756-4C497436-8095-4ECB-ADFC-7391CFBC7A04Q38016170-181D26B1-109C-43FA-BCF1-8E6C76F22A37Q38107272-A30FA767-B369-4B1B-9CEF-E9C73BDD3BBCQ38182932-4AB10C10-38D5-43AF-978C-2F4ADB0366EBQ38623164-5BB970E8-B013-4673-840D-E8D98798F660Q38780337-4DC35CFA-18C7-4803-ABB3-82A69968409EQ38941237-EAFA8C8B-6B7D-46B6-869F-3A018C50E36FQ40090728-D5B5E384-CC80-4771-AA37-364356829B99Q41007502-EC4FC9FD-689A-4738-8279-CFF03B99453CQ42996940-FCEEEA73-FB9C-4301-918C-3E5441036C8CQ43494882-BB5AAC94-0961-4F84-BDF5-BC38FB8B3D37Q59100849-1C7264DE-F134-4D0D-A519-65E464A33CC8Q59136237-E6A2198C-E496-4BE1-BB98-22CA5819B21B
P2860
Complete characterization of the microRNAome in a patient with acute myeloid leukemia
description
2010 nî lūn-bûn
@nan
2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Complete characterization of the microRNAome in a patient with acute myeloid leukemia
@ast
Complete characterization of the microRNAome in a patient with acute myeloid leukemia
@en
Complete characterization of the microRNAome in a patient with acute myeloid leukemia
@nl
type
label
Complete characterization of the microRNAome in a patient with acute myeloid leukemia
@ast
Complete characterization of the microRNAome in a patient with acute myeloid leukemia
@en
Complete characterization of the microRNAome in a patient with acute myeloid leukemia
@nl
prefLabel
Complete characterization of the microRNAome in a patient with acute myeloid leukemia
@ast
Complete characterization of the microRNAome in a patient with acute myeloid leukemia
@en
Complete characterization of the microRNAome in a patient with acute myeloid leukemia
@nl
P2093
P2860
P1433
P1476
Complete characterization of the microRNAome in a patient with acute myeloid leukemia
@en
P2093
Daniel C Koboldt
Daniel C Link
Elaine R Mardis
Giridharan Ramsingh
Katherine B Chiappinelli
Li-Wei Chang
Maria Trissal
Paul Goodfellow
Rakesh Nagarajan
P2860
P304
P356
10.1182/BLOOD-2010-05-285395
P407
P577
2010-09-28T00:00:00Z